Brinker Capital Investments, LLC Amgen Inc Transaction History

Brinker Capital Investments, LLC

$5.01 Billion
Q4 2022

A detailed history of Brinker Capital Investments, LLC transactions in Amgen Inc stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 22,014 shares of AMGN stock, worth $7.09 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

22,014

Previous 24,070 8.54%

Holding current value

$7.09 Million

Previous $5.43 Million 6.56%

% of portfolio

0.12%

Previous 0.11%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$229.03 - $291.01 $470,885 - $598,316	-2,056 Reduced 8.54%	22,014 $5.78 Million
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $225,806 - $254,668	-1,006 Reduced 4.01%	24,070 $5.43 Million
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $671,827 - $747,626	-2,912 Reduced 10.4%	25,076 $6.1 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $219,708 - $243,055	1,002 Added 3.71%	27,988 $6.77 Million
Q4 2021 Feb 08, 2022	BUY	$198.88 - $227.6 $1.97 Million - $2.25 Million	9,905 Added 57.99%	26,986 $6.07 Million
Q2 2021 Aug 03, 2021	BUY	$233.58 - $259.14 $422,312 - $468,525	1,808 Added 11.84%	17,081 $4.16 Million
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $1.07 Million - $1.24 Million	-4,808 Reduced 23.94%	15,273 $3.8 Million
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $275,451 - $328,013	1,273 Added 6.77%	20,081 $4.62 Million
Q3 2020 Dec 03, 2020	BUY	$234.65 - $260.95 $4.41 Million - $4.91 Million	18,808 New	18,808 $4.78 Million
Q1 2020 May 13, 2020	SELL	$182.24 - $241.7 $28,611 - $37,946	-157 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$189.21 - $243.2 $18,921 - $24,320	100 Added 175.44%	157 $38,000
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $121,180 - $145,199	-696 Reduced 92.43%	57 $11,000
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $71,347 - $83,635	428 Added 131.69%	753 $139,000
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $55,527 - $62,591	307 Added 1705.56%	325 $62,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $3,335 - $3,760	18 New	18 $4,000
Q4 2017 Feb 12, 2018	SELL	$168.79 - $188.59 $2,531 - $2,828	-15 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $1,505 - $1,719	9 Added 150.0%	15 $3,000
Q2 2017 Aug 08, 2017	BUY	N/A	6	6 $1,000

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Account

Brinker Capital Investments, LLC Amgen Inc Transaction History